STOCK TITAN

Johnson Controls International plc (JCI) Financials

JCI
Trailing 12 months to March 31, 2026
Revenue $24.4B +5.1% YoY
Net Income $3.5B +41.0% YoY
EPS (Diluted) $5.53 +47.9% YoY
Free Cash Flow $2.7B +15.4% YoY
Market Cap $92.3B as of Oct 14, 2026
Price / Sales 3.8x on $24.4B revenue, trailing 12 months to March 31, 2026
Price / Earnings 26.2x on $3.5B net income, trailing 12 months to March 31, 2026
Price / Book 6.8x on $13.5B equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 14, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Mar 31, 2026 Reported Currency USD FYE September

Newest figures come from the 10-Q for Q2 FY2026, filed May 6, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the JCI SEC filings page.

Johnson Controls International plc (JCI) reported $24.4B in revenue over the twelve months to Mar 31, 2026, up 5.1% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI JCI FY2025

Profit rose far faster than sales in FY2025 despite modest revenue growth, while buybacks increased balance-sheet leverage.

FY2025 net margin jumped to 13.9% from 7.4% while revenue was nearly flat, so the earnings improvement was not primarily a volume story. Buybacks totaled $5.991B against $2.120B of free cash flow, indicating distributions were not funded solely by annual internally generated cash.

Gross margin widened from 35.2% to 36.4%, but net margin expanded more sharply, pointing to improvement below the gross-profit line rather than a broad change in the revenue-cost spread. Net income of $3.291B exceeded operating cash flow of $2.554B, while free cash flow remained positive after capital spending.

The current ratio stayed below 1.0x in FY2025, with current liabilities exceeding current assets; that indicates a tight short-term working-capital posture rather than a cash-rich balance sheet. Total liabilities declined from $26.597B to $25.012B, yet leverage still increased because equity contracted faster than liabilities.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 28 / 100
Financial Health Score 28/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Johnson Controls International plc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
0

Not available for Johnson Controls International plc, and counted as zero in the overall score.

Growth
41

Johnson Controls International plc's revenue grew a modest 2.8% year-over-year to $23.6B. This slow but positive growth earns a score of 41/100.

Leverage
55

Johnson Controls International plc has a moderate D/E ratio of 0.66. This balance of debt and equity financing earns a leverage score of 55/100.

Liquidity
16

Johnson Controls International plc's current ratio of 0.93 is below the typical benchmark, resulting in a score of 16/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow
55

Johnson Controls International plc has a free cash flow margin of 9.0%, earning a moderate score of 55/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns
0

Not available for Johnson Controls International plc, and counted as zero in the overall score.

Piotroski F-Score Neutral
6/9

Johnson Controls International plc passes 6 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Mixed
0.78x

For every $1 of reported earnings, Johnson Controls International plc generates $0.78 in operating cash flow ($2.6B OCF vs $3.3B net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$6.1B
YoY+8.2%
QoQ+6.0%
5Y CAGR+1.9%
10Y CAGR+10.2%

Johnson Controls International plc generated $6.1B in revenue in Q2 2026. This represents an increase of 8.2% from the same quarter a year earlier. Against the prior quarter it is up 6.0%.

Net Income
$613.0M
YoY+28.2%
QoQ+17.0%
5Y CAGR+12.3%

Johnson Controls International plc reported $613.0M in net income in Q2 2026. This represents an increase of 28.2% from the same quarter a year earlier. Against the prior quarter it is up 17.0%.

EPS (Diluted)
$1.00
YoY+38.9%
QoQ+17.6%
5Y CAGR+15.8%

Johnson Controls International plc earned $1.00 per diluted share (EPS) in Q2 2026. This represents an increase of 38.9% from the same quarter a year earlier. Against the prior quarter it is up 17.6%.

EBITDA

Not reported for Q2 2026.

Cash & Balance Sheet

Free Cash Flow
$604.0M
YoY+32.5%
QoQ+13.7%
5Y CAGR+2.3%
10Y CAGR+4.9%

Johnson Controls International plc generated $604.0M in free cash flow in Q2 2026, representing cash available after capex. This represents an increase of 32.5% from the same quarter a year earlier. Against the prior quarter it is up 13.7%.

Cash & Debt
$698.0M
YoY-12.2%
QoQ+26.4%
5Y CAGR-18.0%
10Y CAGR+9.1%

Johnson Controls International plc held $698.0M in cash against $8.6B in long-term debt as of Q2 2026.

Dividends Per Share
$0.40
YoY+8.1%
QoQ0.0%

Johnson Controls International plc paid $0.40 per share in dividends in Q2 2026. This represents an increase of 8.1% from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding
610M
YoY-7.3%
QoQ-0.3%
5Y CAGR-3.2%
10Y CAGR+3.7%

Johnson Controls International plc had 610M shares outstanding in Q2 2026. This represents a decrease of 7.3% from the same quarter a year earlier. Against the prior quarter it is down 0.3%.

Margins & Returns

Gross Margin
36.8%
YoY+0.4pp
QoQ+1.1pp
5Y change+2.1pp
10Y change+84.7pp

Johnson Controls International plc's gross margin was 36.8% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 0.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.1 percentage points.

Net Margin
10.0%
YoY+1.6pp
QoQ+0.9pp
5Y change+3.9pp
10Y change+32.7pp

Johnson Controls International plc's net profit margin was 10.0% in Q2 2026, showing the share of revenue converted to profit. This is up 1.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.9 percentage points.

Return on Equity
4.5%
YoY+1.5pp
QoQ+0.6pp
5Y change+2.6pp
10Y change+17.3pp

Johnson Controls International plc's ROE was 4.5% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 1.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.6 percentage points.

Operating Margin

Not reported for Q2 2026.

Capital Allocation

Share Buybacks
$215.0M
YoY-34.8%
5Y CAGR-7.4%

Johnson Controls International plc spent $215.0M on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 34.8% from the same quarter a year earlier.

Capital Expenditures
$68.0M
YoY-27.7%
QoQ-15.0%
5Y CAGR-8.5%
10Y CAGR-12.6%

Johnson Controls International plc invested $68.0M in capex in Q2 2026, funding long-term assets and infrastructure. This represents a decrease of 27.7% from the same quarter a year earlier. Against the prior quarter it is down 15.0%.

R&D Spending

Not reported for Q2 2026.

JCI Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

JCI quarterly income statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Revenue$6.1B+8.2%$5.8B+6.8%$6.4B+3.1%$6.1B+2.6%$5.7B+1.4%$5.4B+4.2%$6.2B+155.6%$5.9B-17.3%
Cost of Revenue$3.9B+7.6%$3.7B+6.4%$4.1B+2.8%$3.8B+0.4%$3.6B-1.9%$3.5B+2.0%$4.0B+183.7%$3.8B-19.4%
Gross Profit$2.3B+9.3%$2.1B+7.7%$2.4B+3.7%$2.2B+6.5%$2.1B+7.6%$1.9B+8.3%$2.3B+117.9%$2.1B-13.2%
SG&A Expenses$1.4B-1.8%$1.2B-12.7%$1.5B+11.2%$1.4B+58.3%$1.4B-30.9%$1.4B+4.9%$1.4B+100.6%$895.0M-42.4%
Interest Expense$60.0M+7.1%$42.0M-37.3%N/AN/A$56.0M$67.0MN/AN/A
Income Tax$126.0M+384.6%$152.0M+223.4%$85.0M-22.7%$87.0M-50.0%$26.0M+117.0%$47.0M+335.0%$110.0M+154.5%$174.0M+152.9%
Net Income$613.0M+28.2%$524.0M+25.1%$1.7B+167.5%$701.0M-28.1%$478.0M+272.6%$419.0M+12.0%$633.0M+15.3%$975.0M-7.1%
EPS (Basic)$1.01+38.4%$0.86+36.5%$2.61+174.7%$1.07-26.2%$0.73+278.0%$0.63+14.5%$0.95+18.7%$1.45-5.8%
EPS (Diluted)$1.00+38.9%$0.85+34.9%$2.61+177.7%$1.07-26.2%$0.72+275.6%$0.63+14.5%$0.94+17.5%$1.45-5.2%
Diluted Shares (Avg)614M-7.1%614M-7.7%N/A657M-2.3%661M-2.7%665M-2.5%N/A673M-2.0%

Not reported in any period shown, so not listed: R&D Expenses, Operating Income, EBITDA.

JCI Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

JCI quarterly balance sheet
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Total Assets$38.4B-9.5%$38.0B-9.8%$37.9B-11.1%$43.4B+0.2%$42.4B-2.5%$42.1B-4.3%$42.7B+1.1%$43.3B+1.3%
Current Assets$11.0B-3.2%$10.4B-7.5%$10.2B-9.1%$11.8B-2.5%$11.3B-4.4%$11.3B-6.3%$11.2B+4.1%$12.2B+1.2%
Cash & Equivalents$698.0M-12.2%$552.0M-55.4%$379.0M-37.5%$731.0M-14.8%$795.0M-5.1%$1.2B-31.2%$606.0M-26.8%$858.0M-18.8%
Short-Term Investments$0$0$0$0$0$0$0$0
Inventory$1.9B+10.1%$1.9B+11.1%$1.8B+2.6%$1.8B-36.1%$1.8B-41.3%$1.7B-42.1%$1.8B-5.2%$2.9B-7.4%
Accounts Receivable$6.6B+12.9%$6.2B+10.3%$6.3B+3.6%$6.2B-7.7%$5.9B-12.4%$5.6B-7.1%$6.1B+10.1%$6.7B+1.9%
Long-Term Investments$0$0$0$0$0$0$0$0
Goodwill$16.5B+0.2%$16.6B+1.3%$16.6B-0.6%$16.7B-5.5%$16.5B-7.0%$16.4B-9.4%$16.7B-0.3%$17.7B+0.2%
Total Liabilities$24.8B-6.5%$24.8B-5.4%$25.0B-6.0%$27.6B+0.8%$26.6B-4.4%$26.2B-4.0%$26.6B+3.5%$27.4B+3.4%
Current Liabilities$10.6B-10.3%$10.5B-5.3%$10.9B-8.5%$12.3B-2.9%$11.8B-13.1%$11.1B-10.7%$12.0B+7.9%$12.7B+14.3%
Non-Current Liabilities$14.2B+5.1%$14.2B+2.6%$14.0B+5.0%$14.0B+4.0%$13.5B+3.8%$13.9B+1.4%$13.4B-0.6%$13.5B-5.2%
Long-Term Debt$8.6B+5.5%$8.7B+1.3%$8.6B+7.3%$8.4B+7.4%$8.2B+11.1%$8.6B+7.9%$8.0B+2.4%$7.9B-7.4%
Total Equity$13.5B-14.5%$13.2B-17.0%$12.9B-19.7%$15.8B-0.9%$15.8B+0.9%$15.9B-4.8%$16.1B-2.7%$16.0B-2.2%
Retained Earnings$0-100.0%$278.0M-59.8%$0-100.0%$746.0M-10.2%$599.0M+18.1%$691.0M-54.1%$848.0M-38.7%$831.0M-24.4%

JCI Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

JCI quarterly cash flow statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Operating Cash Flow$672.0M+22.2%$611.0M+145.4%$968.0M-28.4%$787.0M+20.5%$550.0M+388.0%$249.0M+201.2%$1.4B+31.9%$653.0M-19.7%
Depreciation & Amortization$169.0M-16.3%$164.0M-15.0%$280.0M+45.8%$190.0M-5.5%$202.0M-6.0%$193.0M-7.2%$192.0M+54.8%$201.0M-5.2%
Stock-Based CompensationN/A$34.0M+21.4%N/AN/AN/A$28.0M-3.4%N/AN/A
Capital Expenditures$68.0M-27.7%$80.0M-31.0%$130.0M-33.3%$94.0M+5.6%$94.0M-26.6%$116.0M+41.5%$195.0M+143.8%$89.0M-19.8%
Free Cash Flow$604.0M+32.5%$531.0M+299.2%$838.0M-27.6%$693.0M+22.9%$456.0M+242.9%$133.0M+140.5%$1.2B+22.4%$564.0M-19.7%
Investing Cash FlowN/AN/AN/AN/AN/AN/AN/A-$99.0M+62.2%
Financing Cash FlowN/A-$464.0M-330.8%N/AN/AN/A$201.0M-83.6%N/A-$999.0M+27.2%
Dividends Paid$244.0M-0.4%$245.0M0.0%$243.0M-1.6%$243.0M-2.4%$245.0M-2.8%$245.0M-2.8%$247.0M-1.6%$249.0M+0.4%
Share Buybacks$215.0M-34.8%$0-100.0%$5.0B+1257.0%$310.0M-22.9%$330.0M-30.4%$330.0M$370.0M+2983.3%$402.0M+9.8%

JCI Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

JCI quarterly financial ratios
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Gross Margin36.8%+0.4pp35.8%+0.3pp36.5%+0.2pp37.1%+1.4pp36.4%+2.1pp35.5%+1.4pp36.3%-6.3pp35.8%+1.7pp
Net Margin10.0%+1.6pp9.0%+1.3pp26.3%+16.1pp11.6%-5.0pp8.4%+13.4pp7.7%+0.5pp10.1%-12.3pp16.5%+1.8pp
Return on Equity4.5%+1.5pp4.0%+1.3pp13.1%+9.2pp4.4%-1.7pp3.0%+4.8pp2.6%+0.4pp3.9%+0.6pp6.1%-0.3pp
Return on Assets1.6%+0.5pp1.4%+0.4pp4.5%+3.0pp1.6%-0.6pp1.1%+1.8pp1.0%+0.1pp1.5%+0.2pp2.3%-0.2pp
Current Ratio1.04+0.1x0.990.0x0.930.0x0.960.0x0.96+0.1x1.020.0x0.940.0x0.96-0.1x
Debt-to-Equity0.64+0.1x0.66+0.1x0.66+0.2x0.530.0x0.520.0x0.54+0.1x0.500.0x0.490.0x
Asset Turnover0.160.0x0.150.0x0.170.0x0.140.0x0.130.0x0.130.0x0.15+0.1x0.140.0x
FCF Margin9.8%+1.8pp9.2%+6.7pp13.0%-5.5pp11.5%+1.9pp8.0%+13.7pp2.5%+8.8pp18.5%-20.1pp9.6%-0.3pp

Not reported in any period shown, so not listed: Operating Margin.

Note: The current ratio is below 1.0 (0.93), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Johnson Controls International plc JCI FY2025 $23.6B $3.3B 14.0% $92.3B 28/100
Trane Technologies plc TT FY2025 $21.3B $2.9B 13.7% $105.2B 68/100
Carrier Global Corporation CARR FY2025 $21.7B $1.5B 6.8% $45.4B 49/100
Lennox International Inc. LII FY2025 $5.2B $805.8M 15.5% $12.1B 63/100
Carlisle Companies, Inc. CSL FY2025 $5.0B $740.7M 14.8% $13.1B 70/100
Masco Corporation MAS FY2025 $7.6B $810.0M 10.7% $13.8B 61/100

Frequently Asked Questions

What is Johnson Controls International plc's annual revenue?

Johnson Controls International plc (JCI) reported $23.6B in total revenue for fiscal year 2025. This represents a 2.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Johnson Controls International plc's revenue growing?

Johnson Controls International plc (JCI) revenue grew by 2.8% year-over-year, from $23.0B to $23.6B in fiscal year 2025.

Is Johnson Controls International plc profitable?

Yes, Johnson Controls International plc (JCI) reported a net income of $3.3B in fiscal year 2025, with a net profit margin of 14.0%.

Johnson Controls International plc (JCI) reported diluted earnings per share of $5.03 for fiscal year 2025. This represents a 99.6% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

As of fiscal year 2025, Johnson Controls International plc (JCI) had $379.0M in cash and equivalents against $8.6B in long-term debt.

Johnson Controls International plc (JCI) had a gross margin of 36.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Johnson Controls International plc (JCI) had a net profit margin of 14.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Yes, Johnson Controls International plc (JCI) paid $1.51 per share in dividends during fiscal year 2025.

Johnson Controls International plc (JCI) has a return on equity of 25.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Johnson Controls International plc (JCI) generated $2.1B in free cash flow during fiscal year 2025. This represents a 97.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Johnson Controls International plc (JCI) generated $2.6B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Johnson Controls International plc (JCI) had $37.9B in total assets as of fiscal year 2025, including both current and long-term assets.

Johnson Controls International plc (JCI) invested $434.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Johnson Controls International plc (JCI) invested $273.0M in research and development during fiscal year 2025.

Yes, Johnson Controls International plc (JCI) spent $6.0B on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Johnson Controls International plc (JCI) had 611M shares outstanding as of fiscal year 2025.

Johnson Controls International plc (JCI) had a current ratio of 0.93 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

Johnson Controls International plc (JCI) had a debt-to-equity ratio of 0.66 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Johnson Controls International plc (JCI) had a return on assets of 8.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Johnson Controls International plc (JCI) trades at 26.2x earnings, its market capitalization divided by net income of $3.5B net income, trailing 12 months to March 31, 2026. The market capitalization is $92.3B as of Oct 14, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Johnson Controls International plc (JCI) trades at 3.8x sales, its market capitalization divided by revenue of $24.4B revenue, trailing 12 months to March 31, 2026. The market capitalization is $92.3B as of Oct 14, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Johnson Controls International plc (JCI) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Johnson Controls International plc (JCI) has an earnings quality ratio of 0.78x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Johnson Controls International plc (JCI) scores 28 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top